Altair Signs Contract with Top Pharmaceutical Contract Research Organization
PLANO, TX (April 14, 2014) – Altair Global announced in April that it will begin providing fully outsourced global relocation and assignment services for a key company in the pharmaceutical, biotech, and medical device industries.
Our new client assists biotech and pharmaceutical companies to efficiently develop new drugs by delivering first-rate clinical, nonclinical, and commercialization services. The company has helped develop one-third of all prescription medicine currently in the market. Presently, the client has offices in 60 countries with 11,800 employees.
“The company was looking for a relocation management company that could reduce corporate relocation management expenses and provide excellent technology capabilities,” says Pete Larkin, Vice President, Business Development for Altair.
“The company believed Altair was the best fit due to our global mobility expertise and seamless integration between operations and accounting,” says Lauri Murphy, Vice President, EMEA, for Altair.